GlaxoSmithkline Pharmaceuticals Limited (BSE:500660) is looking to sell a part or all of its 72.5% stake in GlaxoSmithKline Consumer Healthcare Limited (BSE:500676). It started a review on March 2018. Potential bidders include PepsiCo, Inc. (nadaqGS:PEP) General Mills, Inc. (NYSE:GIS) and Kellogg Company (NYSE:K), apart from the main contenders Unilever PLC (LSE:ULVR), Nestle India Limited (BSE:500790) and Coca-Cola India Private Limited.

Nestlé S.A., Unilever and The Coca-Cola Company are advancing on a potential acquisition of GlaxoSmithKline Consumer Healthcare Limited (BSE:500676) for about $4 billion.